Yan Zou

Shanghai University — China

Materials Science · Physical Sciences

49h-index7.6kcitations245works4.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Nanoparticle-Based Drug Delivery(44), Nanoplatforms for cancer theranostics(36), RNA Interference and Gene Delivery(28), Advanced biosensing and bioanalysis techniques(18), Glioma Diagnosis and Treatment(15)

Publications245 total

Fuzheng Kang'ai Formula suppresses NSCLC by inducing a functional crosstalk between autophagy and ferroptosis via EZH2/DOT1L/H3K79me2 signaling
Phytomedicine·2025
Development status and trend prospect of spectral on-site detection technology
2025
In vitro Evaluation of Mitochondrial-Targeted Andrographolide Nanoparticles Against 4T1 Breast Cancer Cells
International Journal of Nanomedicine·2025Open Access
Lab-to-scale review: Synthesis, application, and economic feasibility of LDHs-biochar composites for wastewater treatment
Journal of environmental chemical engineering·2025
Natural Ginger-Derived Exosomes as Effective Therapeutics for Glioblastoma
Nano Letters·2025
Hepatocyte proteome destabilization and novel targets for PFASs unveiled through combined thermal proteome profiling and deep transfer learning
Journal of Hazardous Materials·2025
Sensitivity evaluation and prediction of extreme rainfall-induced landslides in Xinning, Hunan China, using Gumbel extreme value theory and random forest model
2025Open Access
Glymphatic dysfunction as an indicator of disease burden and a potential biomarker in anti‐ <scp>NMDAR</scp> encephalitis
Psychiatry and Clinical Neurosciences·2025
Transcription factor EGR2 drives cataract formation through IGFBP3-mediated oxidative injury in lens epithelial cells
Free Radical Biology and Medicine·2025
A Model‐Based Meta‐Analysis of Pembrolizumab Effects on Patient‐Reported Quality of Life: Advancing Patient‐Centered Oncology Drug Development
UNC Libraries·2025Open Access
Non-invasive CRISPR/Cas9 nanocapsules specifically edit α-synuclein for effective Parkinson’s disease treatment
Nano Today·2025
A Model‐Based Meta‐Analysis of Pembrolizumab Effects on Patient‐Reported Quality of Life: Advancing Patient‐Centered Oncology Drug Development
CPT Pharmacometrics & Systems Pharmacology·2025· 1 citedOpen Access
Deep Survival Analysis for Competing Risk Modeling with Functional Covariates and Missing Data Imputation
arXiv (Cornell University)·2025Open Access
Intensity-Modulated Proton Therapy for an Unresectable Giant Non-functioning Pituitary Adenoma: A Case Report and Literature Review
Cureus·2025Open Access
Tannic Acid–Iron Complex-Based Nanozyme Ameliorates Parkinson’s Disease via Relieving Oxidative Stress and Neuroinflammation
ACS Nano·2025· 9 cited
Ligand conformational adaptability modulated self-assembly of Solomon links ( <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" altimg="si1.svg"> <mml:mrow> <mml:msubsup> <mml:mn>4</mml:mn> <mml:mn>1</mml:mn> <mml:mn>2</mml:mn> </mml:msubsup> </mml:mrow> </mml:math> ) and trefoil knots (31)
Chinese Journal of Structural Chemistry·2025· 2 cited
Case Report: Multimodal management of a rare pediatric astroblastoma using proton beam therapy and Gamma Knife radiosurgery—a case report and literature review
Frontiers in Oncology·2025· 1 citedOpen Access
Changes in Gut Microbiota, Midgut Structure, and Gene Expression of Spodoptera frugiperda Infected by Serratia marcescens
Insects·2025Open Access
Cathodic electrodeposition activation of NiFe-based metal–organic frameworks for enhanced oxygen evolution reaction
Rare Metals·2025· 3 cited
Postoperative Proton Beam Therapy for Intracranial Mesenchymal Tumors: Clinical Outcomes and Literature Review
2025Open Access
page 1 of 13Next →

Frequent Co-authors

Meng Zheng(19), Bingyang Shi(18), Zhiyuan Zhong(18), Fenghua Meng(17), Chao Deng(10), Dongya Zhang(9), Yibin Wang(6), Wei Tao(6), Roger S. Chung(6), Weijing Yang(6), Jinlong Yin(5), Ru Cheng(5), Weimin Ruan(4), Lei Fan(3), Can Liu(3), Lei Zhou(3), Yang Liu(3), Haigang Wu(3), Xue Xue(3), David B. Lovejoy(3)